5311462026-09-035311462026-09-032026-09-03RelatedPartyTransactionDomain15311462026-09-032026-09-03RelatedPartyTransactionDomain25311462026-09-032026-09-03ResolutionOrAgendaDomain15311462026-09-03ResolutionOrAgendaDomain15311462026-09-032026-09-03ResolutionOrAgendaDomain25311462026-09-03ResolutionOrAgendaDomain25311462026-09-032026-09-03ResolutionOrAgendaDomain35311462026-09-03ResolutionOrAgendaDomain35311462026-09-032026-09-03ResolutionOrAgendaDomain45311462026-09-03ResolutionOrAgendaDomain45311462026-09-032026-09-03ResolutionOrAgendaDomain55311462026-09-03ResolutionOrAgendaDomain55311462026-09-032026-09-03ResolutionOrAgendaDomain65311462026-09-03ResolutionOrAgendaDomain65311462026-09-032026-09-03ResolutionOrAgendaDomain75311462026-09-03ResolutionOrAgendaDomain75311462026-09-032026-09-03ResolutionOrAgendaDomain85311462026-09-03ResolutionOrAgendaDomain8iso4217:INRxbrli:pureMEDICAMEN BIOTECH LIMITEDMEDICAMEQNew2026-09-2612:00:002026-09-03Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)1SATURDAY2026-09-2612:00:001506, Chiranjiv Tower, 43, Nehru Place, New Delhi-1100198MEDICAMEN BIOTECH LIMITEDMEDICAMEN LIFE SCIENCES PRIVATE LIMITEDSUBSIDIARY COMPANYPurchase of goods or services3000000002026-09-262027-09-26MEDICAMEN BIOTECH LIMITEDShivalik Rasayan LimitedHOLDING COMPANYSale of goods or services3000000002026-09-262027-09-26Ordinary ResolutionAdoption of Financial StatementsTo receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended 31st March, 2026 and the reports of the Board of Directors and Statutory Auditor thereonOrdinary ResolutionAdoption of Financial StatementsTo receive, consider and adopt the audited consolidated financial statements of the Company for the financial year ended 31st March, 2026 and the report of the Statutory Auditor thereonOrdinary ResolutionOthersOthersTo declare dividend on equity shares“Resolved that the final dividend of Rs. 1 /- (Rupees One only) per equity share (i.e. 10% on the face value of 10/-), as recommended by the Board of Directors, for the financial year ended 31st March, 2026, be and is hereby declared.”Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRetirement by rotationTo re-appoint Mr Suresh Kumar Singh (DIN: 00318015) as a director liable to retire by rotationNon-Executive - Non-Independent DirectorSuresh Kumar Singh003180152026-09-262027-09-26Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRetirement by rotationTo re-appoint Mr Sanjay Bansal (DIN: 00121667) as a director liable to retire by rotationNon-Executive - Non-Independent DirectorSanjay Bansal001216672026-09-262027-09-26Ordinary ResolutionOthersOthersRatification of Remuneration of Cost Auditors“RESOLVED THAT pursuant to the provisions of Section 148(3) and other applicable provisions, if any, of the Companies Act, 2013 [including any statutory modification(s) or re-enactment(s) thereof for the time being in force] read with the Companies (Audit and Auditors) Rules, 2014, as amended from time to time, the Company hereby ratifies the remuneration of Rs. 2,00,000/- plus applicable taxes and out-of-pocket expenses incurred in connection with the cost audit payable to SPB & Co., Cost Accountants (Firm Registration No. 102586), who are appointed by the Board of Directors of the Company on the recommendation of the Audit Committee, as Cost Auditors of the Company to conduct audit of the cost records maintained by the Company as prescribed under the Companies (Cost Records and Audit) Rules, 2014, as amended from time to time, for the financial year ending March 31, 2027.Ordinary ResolutionRelated Party TransactionTo approve material related party transactions with Shivalik Rasayan Limited (Holding Company)Ordinary ResolutionRelated Party TransactionTo approve material related party transactions with Medicamen Life Sciences Private Limited (Subsidiary Company)